Saturday, February 9, 2013 Friday, February 8, 2013 Thursday, February 7, 2013- How Far Can This Blockbuster Take Johnson & Johnson?at Motley Fool (Thu, Feb 7)
- Pfizer's Increasing Cash May Signify More Repurchases Or A One-Time Dividendat Seeking Alpha (Thu, Feb 7)
- Pfizer Breakup Talk Stoked by Discount to Drug Stocksat Bloomberg (Thu, Feb 7)
- Protalix Exploring OptionsZacks (Thu, Feb 7)
- 50% Upside on this Biotechnology Stockat Motley Fool (Thu, Feb 7)
- Data on Auxilium's XiaflexZacks (Thu, Feb 7)
- Best of the Biotech Industryat Motley Fool (Thu, Feb 7)
- Favorable Ruling for PfizerZacks (Thu, Feb 7)
- Investors Pull Back After Yesterday's Rallyat Motley Fool (Thu, Feb 7)
- The Investor's Guide to Zoetisat Motley Fool (Thu, Feb 7)
- Teva Pharmaceutical 4Q profit falls 37 percentAP (Thu, Feb 7)
- FDA May Relax Guidlines on Early-Stage Alzheimer’s Trialsat Bloomberg (Thu, Feb 7)
- Lilly stops rheumatoid arthritis treatment studyAP (Thu, Feb 7)
- New Stock Coverage: AOL Not Dialing Up Dollarsat Minyanville (Thu, Feb 7)
- Analysts' Actions: GOOG YHOO JNJ PFE TWXTheStreet (Thu, Feb 7)
- Cramer's Lightning Round - Dynavax Is Coming Back (2/6/13)at Seeking Alpha (Thu, Feb 7)
- The Impending Spinoff of a Spinoffat Motley Fool (Thu, Feb 7)
Add PFE News to My Yahoo!  | |
|